A Phase 1 Trial of Stereotactic Ablative Radiation Therapy (SABR) for Oligometastatic Cancer: Toxicity and Quality of Life

Authors :: Edward Chow
Patrick Cheung
Natalie Pulenzas
L. Zhang
Arjun Sahgal
Darby Erler
Gillian Bedard
William Chu
Hans Chung
Ian Poon
Source :: International Journal of Radiation Oncology*Biology*Physics. 93:E492
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Cancer Research
medicine.medical_specialty
Radiation
business.industry
medicine.medical_treatment
Cancer
medicine.disease
SABR volatility model
Radiation therapy
Oncology
Quality of life
Ablative case
Toxicity
Medicine
Radiology, Nuclear Medicine and imaging
Radiology
business

Full Text Access

Tools